Ophélie C.
- Country
- France
- Department
- Medical Oncology
Research Overview
- Evaluation of Neo-Adjuvant Chemotherapy with FOLFOX Regimen in Elderly Patients with Locally Advanced Resectable Colon Carcinoma
- Phase 3 Randomized Study of Elacestrant Versus Standard Endocrine Therapy in Node-Positive, ER-Positive, HER2-Negative Early Breast Cancer with High Recurrence Risk
- Evaluation of Dihydropyrimidine Dehydrogenase Activity on Capecitabine Efficacy in Breast Cancer Patients
Data & Insights
Has run more than one trial at 7 of 268 partner sites.
Specializations
Oncology Research
This investigator specializes in the study of breast cancer treatment approaches, with particular emphasis on understanding metabolic factors affecting therapeutic outcomes.
- Breast Cancer Therapeutics
- Metabolic Response Studies
- Treatment Efficacy Analysis
The research focuses on evaluating treatment effectiveness in breast cancer patients, incorporating metabolic activity assessments to optimize therapeutic outcomes.
Pharmacological Studies
Expertise in investigating enzyme activity relationships with cancer treatments, specifically examining metabolic pathways that influence therapeutic responses.
- Drug Metabolism Research
- Enzyme Activity Analysis
- Treatment Response Evaluation
The investigator examines how enzymatic processes affect treatment outcomes in cancer therapy, focusing on personalized treatment approaches.
Treatment Optimization
Dedicated to improving cancer treatment efficacy through the understanding of individual patient metabolic factors and their impact on therapeutic outcomes.
- Patient Response Analysis
- Treatment Effectiveness Studies
- Therapeutic Monitoring
Research efforts center on enhancing treatment effectiveness through metabolic activity assessment and response monitoring.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.